TY - JOUR
T1 - Cytogenetic findings in mantle cell lymphoma
T2 - Cases with a high level of peripheral blood involvement have a distinct pattern of abnormalities
AU - Onciu, M.
AU - Schlette, E.
AU - Medeiros, L. J.
AU - Abruzzo, L. V.
AU - Keating, M.
AU - Lai, R.
N1 - Copyright:
Copyright 2007 Elsevier B.V., All rights reserved.
PY - 2001
Y1 - 2001
N2 - We compared conventional cytogenetic findings in mantle cell lymphomas (MCLs) having an absolute peripheral lymphocytosis of more than 10,000/μL (> 10 x 109/L) at diagnosis ("leukemic"; n = 30) with those in cases having no or minimal lymphocytosis ("nodal"; n = 19). Only cases positive for t(ll;14) were included for study. Forty-six cases (94%) had abnormalities in addition to t(11;14). The most frequent abnormalities involved chromosome 13 (26 cases [53%]), followed by chromosomes 1, 3, 7, 8, 9, 10, 12, 15, 17, and 21 (11-18 cases [22%-37%]). There was no difference in the number of aberrations between the 2 groups. Abnormalities of chromosomes 17, 21, and 22 were more frequent, and breakpoints involving 8q24, 9p22-24, and 16q24 were found exclusively in leukemic MCL. Chromosome 17 aberrations involved were structural (breakpoints involving 17p13,17p11.2, 17q) in leukemic MCL but were only numeric in nodal MCL. Thus, leukemic MCL differs from nodal MCL in their cytogenetic profiles, which may contribute to the clinical presentation.
AB - We compared conventional cytogenetic findings in mantle cell lymphomas (MCLs) having an absolute peripheral lymphocytosis of more than 10,000/μL (> 10 x 109/L) at diagnosis ("leukemic"; n = 30) with those in cases having no or minimal lymphocytosis ("nodal"; n = 19). Only cases positive for t(ll;14) were included for study. Forty-six cases (94%) had abnormalities in addition to t(11;14). The most frequent abnormalities involved chromosome 13 (26 cases [53%]), followed by chromosomes 1, 3, 7, 8, 9, 10, 12, 15, 17, and 21 (11-18 cases [22%-37%]). There was no difference in the number of aberrations between the 2 groups. Abnormalities of chromosomes 17, 21, and 22 were more frequent, and breakpoints involving 8q24, 9p22-24, and 16q24 were found exclusively in leukemic MCL. Chromosome 17 aberrations involved were structural (breakpoints involving 17p13,17p11.2, 17q) in leukemic MCL but were only numeric in nodal MCL. Thus, leukemic MCL differs from nodal MCL in their cytogenetic profiles, which may contribute to the clinical presentation.
KW - Conventional cytogenetics
KW - Leukemia
KW - Lymph node
KW - Mantle cell lymphoma
UR - http://www.scopus.com/inward/record.url?scp=0035180862&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035180862&partnerID=8YFLogxK
U2 - 10.1309/JQMR-323G-71Y9-M7MB
DO - 10.1309/JQMR-323G-71Y9-M7MB
M3 - Article
C2 - 11764078
AN - SCOPUS:0035180862
SN - 0002-9173
VL - 116
SP - 886
EP - 892
JO - American journal of clinical pathology
JF - American journal of clinical pathology
IS - 6
ER -